Polycystic Liver Disease 1 C0887850
Polycystic Liver Disease type 1 causes multiple fluid-filled cysts to form in the liver, often without affecting kidney function. Treatment ranges from monitoring to medication or procedures for symptom relief.
Key facts at a glance
- ICD-10
- K76.9
- ICD-11
- DA00.0
- Body system
- hepatobiliary
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Abdominal pain
(hepatobiliary)Generalized symptoms
(hepatobiliary)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Abdominal distension
(hepatobiliary)Early satiety
(hepatobiliary)Nausea
(hepatobiliary)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Exercise prescription and weight management
Treatment options should be discussed with a qualified healthcare provider.
Regular imaging and symptom assessment
Periodic ultrasound or MRI to monitor cyst burden and evaluate symptoms such as abdominal pain or early satiety.
Weight management program
Body weight reduction to decrease intra-abdominal pressure and improve symptoms related to hepatic cyst burden.
Additional treatment options
Reduced sodium intake
Dietary sodium restriction to minimize fluid retention and reduce abdominal discomfort from enlarged cysts.
dietarySomatostatin analog therapy
Long-acting injectable medication that reduces liver cyst volume by inhibiting fluid secretion into cysts.
medicationLaparoscopic cyst fenestration
Minimally invasive surgical procedure to create windows in cyst walls, allowing fluid drainage and symptom relief.
surgicalWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Polycystic Liver Disease 1 C0887850?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Gevers TJ, Drenth JP. Diagnosis and management of polycystic liver disease. United European Gastroenterology Guidelines. 2020.
Cnossen WR, Drenth JP. Polycystic liver disease: an overview of clinical manifestations and treatment options. Hepatology. 2014.
Petersen KF, Perdigoto R, Torres J. Systematic Review of Pharmacological Treatment for Polycystic Liver Disease. Clin Gastroenterol Hepatol. 2022.
Van Keimpema L, De Koning B, Van Zanten R. Everolimus for Treatment of Polycystic Liver Disease: A Randomized Controlled Trial. Gastroenterology. 2018.
Medication Comparisons
Compare medications used to treat Polycystic Liver Disease 1 C0887850. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy